Study to Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Obeticholic Acid (OCA) Compared to Placebo in Pediatric Participants With Biliary Atresia, Post-hepatoportoenterostomy
Clinical trial NCT06121375 · TERMINATED
Trial details
- NCT number
- NCT06121375
- Sponsor
- Intercept Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-02
- Primary completion
- 2025-10-21
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.